A catastrophe in the 21st century: The public health situation in South Africa following HIV/AIDS

Journal of The Royal Society for the Promotion of Health

Volumn 125, Issue 4, 2005, Pages 168-171

  Walker, Alexander R P ^a   Walker, Betty F ^a   Wadee, Ahmed A ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

African countries; HIV AIDS; Public health; Sexual behaviour

Indexed keywords

ANTIRETROVIRUS AGENT; HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CONDOM; DISEASE TRANSMISSION; FEMALE; GEOGRAPHIC DISTRIBUTION; GOVERNMENT; HEALTH PROGRAM; HEALTH PROMOTION; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; INFECTION RATE; LIFE EXPECTANCY; MALE; MORBIDITY; MORTALITY; POPULATION DISTRIBUTION; POPULATION RESEARCH; PREVALENCE; PUBLIC HEALTH SERVICE; SEX DIFFERENCE; SEXUAL BEHAVIOR; SEXUAL INTERCOURSE; SOCIOECONOMICS; SOUTH AFRICA; STATISTICAL ANALYSIS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; FORECASTING; HIV INFECTIONS; HUMANS; LIFE EXPECTANCY; PUBLIC HEALTH; SOUTH AFRICA;

EID: 23244457389     PISSN: 14664240     EISSN: None     Source Type: Journal    
DOI: 10.1177/146642400512500409     Document Type: Article

References (44)

1. Van Heyningen EB. Public Health and Society: Cape Town in 1880-1910. Doctor of Philosophy Thesis. Department of History, University of Cape Town, 1989
2. South African Year Book, 1999. Pretoria, SA: Government Communication and Information System, 1999
3. South African Health Review, 2000. Durban, SA: Health Systems Trust, 2001
4. Kale R. Impressions of health in the new South Africa: a period of convalescence. BMJ 1995;310(6987):1119-22
5. US Department of Health and Human Services. Centers for Diseases Control and Prevention. National Center for Health Statistics, 1991
6. Seedat YK. Hypertension in black South Africans. J Hum Hypertension 1999;13:96-103
7. Omar MAK, Seedat MA, Motala AA, Dyer RB, Becker P. The prevalence of diabetes mellitus and impaired glucose tolerance in a group of South African blacks. S Afr Med J 1993;83:641-3
8. Iman I. Stroke: a review with an African perspective. Ann Trop Med Parasitology 2002;96(5):435-45
9. Walker ARP. Coronary heart disease in Southern Africa: what of the future? Cardiovasc J S Afr SAMJ suppl 2: 1999;C67-C8
10. Sitas F, Madhoo J, Wessie J. Cancer in South Africa, 1993-1995. National Cancer Registry of South Africa. Johannesburg: South African Institute for Medical Research, 1998
11. Walker ARP. Changes in public health in South Africa from 1876. J Roy Soc Health 2001;121(2):85-93
12. Walker ARP. Epidemiology and health implications of obesity with special reference to African populations. Ecol Food Nutr 1998;37:21-55
13. Gray G. Combating HIV infection in South Africa. SAfAIDS News 2001;9:12-3
14. Ncayiyana DJ. The MRC HIV/AIDS mortality report / South Africa's 'Apocalypse' now. S Afr Med J 2002;92:89
15. Stover J, Walker N, Garnett GP, Salomon JA, Stanecki KA, Ghys PD, et al. Can we reverse the HIV/AIDS pandemic with an expanded response? Lancet 2002;360(9326):73-7
16. Cullinan K. In South Africa HIV infection is decreasing, safe sex increasing. Bull World Health Organ 2003;81(1):72
17. Fassin D, Schneider H. The politics of AIDS in South Africa: beyond the controversies. BMJ 2003;326(7387):495-7
18. Waugh M. AIDS in Africa. Int J STD AIDS 2003;14(3):143
19. Denolf D, Musongela JP, Nzila N, Tahiri M, Colebunders R. The HIV epidemic in Kinshasa, Democratic Republic of Congo. Int J STD AIDS 2001;12(12):823-33
20. Quinn TC, Mann JM, Curran JW, Piot P. AIDS in Africa: an epidemiologic paradigm. 1986. Bull World Health Organ 2001;79(12):1159-67
21. Luo RF. Understanding the threat of HIV/AIDS. JAMA 2002;288(13):1649
22. Kapp C. Global fund on AIDS, tuberculosis and malaria, holds first board meeting. Lancet 2002;359(9304):414
23. Urassa M, Boerma JT, Isingo R, Ngalula J, Ng'weshemi J, Mwaluko G, et al. The impact of HIV/AIDS on mortality and household mobility in rural Tanzania. AIDS 2001;15: 2017-23
24. Anonymous. HIV testing among racial/ethnic minorities - United States, 1999. Morb Mortal Wkly Rep 2001;50(47):1054-8
25. Clinton WJ. Turning the tide on the AIDS pandemic. N Engl J Med 2003;348(18):1800-2
26. Taylor M, Jinabhai CC, Dladla NA, Rangongo MF, Connolly C. HIV/AIDS health education for rural KwaZulu Natal primary schoolchildren. S Afr J Epidemiol Infect 2000;15(4):100-7
27. Buga GA. Cervical awareness and risk factors among female university students. East Afr Med J 1998;75 (7):411-6
28. Grunbaum JA, Kann L, Kinchen SA, Williams B, Ross JG, Lowry R, et al. Youth risk behavior surveillance - United States, 2001. MMWR Surveill Summ 2002;51(4):1-62
29. Gyarmathy VA, Thomas RP, Mikl J, McNutt LA, Morse DL, DeHovitz J, et al. Sexual activity and condom use among Eastern European adolescents: the Study of Hungarian Adolescent Risk Behaviour. Int J STD AIDS 2002;13(6):399-405
30. Lagarde E, Carael M, Glynn JR, Kanhonou L, Abega S, Kahindo M, et al. Educational level is associated with condom use within non-espousal partnerships in four cities of sub-Saharan Africa. AIDS 2001;15(11):1399-408
31. Myer L, Mathews C, Little F, Abdool Karin SS. The fate of free male condoms distributed to the public in South Africa. AIDS 2001;15:789-93
32. Esparza J. An HIV vaccine: how and when? Bull World Health Organ 2001;79(12):1133-7
33. Global situation of the AIDS pandemic, end 2002. Wkly Epidemiol Rec 2002;77(49):417-24
34. Walker ARP, Mitchelow PM, Walker BF. High cervix cancer rates in African women in Durban, South Africa. Int J Gynaecol Obstet 2002;79(1):45-6
35. Steinbrook R. HIV infection - a new drug and new costs. N Engl J Med 2003;348(22):2171-2
36. Current Clinical Issues: Building African AIDS care from the ground up. Ann Intern Med 2003;139:157
37. Guay LA, Musoke P, Fleming T, Bagenda D, Allen M, Nakabiito C, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet 1999;354(9181):795-802
38. Hogg RS, Heath K, Bangsberg GP, Yip B, Press N, O'Shaughnessy MV, et al. Intermittent use of triple-combination therapy is predictive of mortality at base line and after 1 year follow-up. AIDS 2002;16(7):1051-1058
39. Naylor CD. Putting evidence into practice. Am J Med 2002;113(2):161-3
40. Morris L, Williamson C. Host and viral factors that impact on HIV-1 transmission and disease progression in South Africa. S Afr Med J 2001;91(3):212-5
41. Morgan D, Whitworth J. The natural history of HIV-1 infection in Africa. Nat Med 2001;7(2):143-5
42. Ahmed S, Lutalo T, Wawer M, Serwadda D, Sewankambo NK, Nalugoda F, et al. HIV incidence and sexually transmitted disease prevalence associated with condom use: a population study in Rakai, Uganda. AIDS 2001;15(16):2171-9
43. Fylkesnes K, Musonda RM, Sichone M, Ndhlovu Z, Tembo F, Moze M. Declining HIV prevalence and risk behaviors in Zambia: evidence from surveillance and population based surveys. AIDS 2001;15(7):907-16
44. Mukherjee JS, Farmer PE, Niyizonkiza D, McCorkle L, Vanderwarker C, Teixeira P, et al. Tackling HIV in resource poor countries. BMJ 2003;327(7423):1104-6